Literature DB >> 23107897

Early development of secondary hyperparathyroidism following renal transplantation.

Elin Isaksson1, Gunnar Sterner.   

Abstract

BACKGROUND: Optimal levels of intact parathyroid hormone (iPTH) in the post-transplant period are not known due to insufficient data. Therefore, we aimed to describe secondary hyperparathyroidism (SHPT) in Swedish renal transplant (RT) recipients and also report events of fractures and vascular events potentially related to levels of iPTH.
METHODS: Medical charts from 132 RT recipients were retrospectively reviewed. Laboratory/clinical data were obtained at regular points up to 12 months post RT. Three groups were created based on pre-RT levels of iPTH based on KDOQI recommended levels of iPTH in CKD 5.
RESULTS: One year post RT 69% had iPTH above levels recommended by KDOQI. A multiple regression analysis showed a strong relation between pre-transplant iPTH levels and iPTH levels at 12 months (β coefficient = 0.323, p < 0.001). Patients with low pre-transplant levels of iPTH had a higher rate of fractures during follow up compared to patients with higher pre-transplant levels of iPTH (P = 0.034) [corrected].
CONCLUSION: SHPT is common in Swedish RT recipients. Pre-transplant regulation of SHPT is of great importance to determine outcome post RT. Low levels of iPTH in the pre-transplant period could be associated with a high risk of fracture in the first post-transplant year.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23107897     DOI: 10.1159/000342811

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  5 in total

1.  The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism.

Authors:  Kerstin M Ivarsson; Shahriar Akaberi; Elin Isaksson; Eva Reihnér; Rebecca Rylance; Karl-Göran Prütz; Naomi Clyne; Martin Almquist
Journal:  Nephrol Dial Transplant       Date:  2015-09-15       Impact factor: 5.992

2.  Cardiovascular and Cerebrovascular Events After Parathyroidectomy in Patients on Renal Replacement Therapy.

Authors:  Kerstin M Ivarsson; Shahriar Akaberi; Elin Isaksson; Eva Reihnér; Tomasz Czuba; Karl-Göran Prütz; Naomi Clyne; Martin Almquist
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

3.  A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.

Authors:  Josep M Cruzado; Pablo Moreno; José V Torregrosa; Omar Taco; Richard Mast; Carmen Gómez-Vaquero; Carolina Polo; Ignacio Revuelta; José Francos; Joan Torras; Arantxa García-Barrasa; Oriol Bestard; Josep M Grinyó
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

4.  Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients.

Authors:  Josep M Cruzado; Ricardo Lauzurica; Julio Pascual; Roberto Marcen; Francesc Moreso; Alex Gutierrez-Dalmau; Amado Andrés; Domingo Hernández; Armando Torres; Maria Isabel Beneyto; Edoardo Melilli; Anna Manonelles; Manuel Arias; Manuel Praga
Journal:  Kidney Int Rep       Date:  2017-09-28

5.  Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow-up of renal transplant recipients?

Authors:  Elin Isaksson; Martin Almquist; Astrid Seeberger; Gunnar Sterner
Journal:  Clin Exp Nephrol       Date:  2018-02-24       Impact factor: 2.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.